Pacific Edge Says Total Laboratory Throughput Falls Over 13% Quarter-Over-Quarter In Fiscal 2026 Q3

MT Newswires Live

01/20

Pacific Edge (ASX:PEB, NZE:PEB) said total laboratory throughput in during the the three months to the end of December 2025 fell 13.4% to 5,446 tests from 6,286 in the previous quarter and the total laboratory throughput in US declined 19.5% to 4,003 tests from 4,971 in the second quarter of fiscal 2026, according to separate filings with the Australian and New Zealand bourses on Tuesday.

The number of ordering clinicians fell to 691 from 803 in the prior quarter. Asia-Pacific total laboratory throughput rose 9.7% quarter-over-quarter to 1,443 tests from 1,315.

Its Chief Executive, Peter Meintjes, said the throughput challenges were amplified by the seasonal holiday slowdown.

The firm is also pursuing appeals for all eligible Cxbladder Triage tests that were denied Medicare reimbursement since the Cxbladder non-coverage determination took effect in April 2025. The Office of Medicare Hearings and Appeals (OMHA) notified the firm that the first reimbursement appeal has been scheduled for a hearing before an Administrative Law Judge on Feb. 24.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2604629551"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2604629551\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2604629551?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-20 15:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2604629551","market":"nz","top_or_hot":-1,"title":"Pacific Edge Says Total Laboratory Throughput Falls Over 13% Quarter-Over-Quarter In Fiscal 2026 Q3","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (ASX:PEB, NZE:PEB) said total laboratory throughput in during the the three months to the end of December 2025 fell 13.4% to 5,446 tests from 6,286 in the previous quarter and the total laboratory throughput in US declined 19.5% to 4,003 tests from 4,971 in the second quarter of fiscal 2026, according to separate filings with the Australian and New Zealand bourses on Tuesday.</p><p>The number of ordering clinicians fell to 691 from 803 in the prior quarter. Asia-Pacific total laboratory throughput rose 9.7% quarter-over-quarter to 1,443 tests from 1,315.</p><p>Its Chief Executive, Peter Meintjes, said the throughput challenges were amplified by the seasonal holiday slowdown.</p><p>The firm is also pursuing appeals for all eligible Cxbladder Triage tests that were denied Medicare reimbursement since the Cxbladder non-coverage determination took effect in April 2025. The Office of Medicare Hearings and Appeals (OMHA) notified the firm that the first reimbursement appeal has been scheduled for a hearing before an Administrative Law Judge on Feb. 24.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pacific Edge Says Total Laboratory Throughput Falls Over 13% Quarter-Over-Quarter In Fiscal 2026 Q3</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPacific Edge Says Total Laboratory Throughput Falls Over 13% Quarter-Over-Quarter In Fiscal 2026 Q3\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-20 15:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (ASX:PEB, NZE:PEB) said total laboratory throughput in during the the three months to the end of December 2025 fell 13.4% to 5,446 tests from 6,286 in the previous quarter and the total laboratory throughput in US declined 19.5% to 4,003 tests from 4,971 in the second quarter of fiscal 2026, according to separate filings with the Australian and New Zealand bourses on Tuesday.</p><p>The number of ordering clinicians fell to 691 from 803 in the prior quarter. Asia-Pacific total laboratory throughput rose 9.7% quarter-over-quarter to 1,443 tests from 1,315.</p><p>Its Chief Executive, Peter Meintjes, said the throughput challenges were amplified by the seasonal holiday slowdown.</p><p>The firm is also pursuing appeals for all eligible Cxbladder Triage tests that were denied Medicare reimbursement since the Cxbladder non-coverage determination took effect in April 2025. The Office of Medicare Hearings and Appeals (OMHA) notified the firm that the first reimbursement appeal has been scheduled for a hearing before an Administrative Law Judge on Feb. 24.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7067","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2604629551","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2604629551","pubTimestamp":1768892890,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pacific Edge  said total laboratory throughput in during the the three months to the end of December 2025 fell 13.4% to 5,446 tests from 6,286 in the previous quarter and the total laboratory throughput in US declined 19.5% to 4,003 tests from 4,971 in the second quarter of fiscal 2026, according to separate filings with the Australian and New Zealand bourses on Tuesday.The number of ordering clinicians fell to 691 from 803 in the prior quarter. Asia-Pacific total laboratory throughput rose 9.7% quarter-over-quarter to 1,443 tests from 1,315.Its Chief Executive, Peter Meintjes, said the throughput challenges were amplified by the seasonal holiday slowdown.The firm is also pursuing appeals for all eligible Cxbladder Triage tests that were denied Medicare reimbursement since the Cxbladder non-coverage determination took effect in April 2025. The Office of Medicare Hearings and Appeals  notified the firm that the first reimbursement appeal has been scheduled for a hearing before an Admini","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7067":"生物科技","PEB.NZ":"Pacific Edge Limited Ordinary Shares","BK8033":"生物科技","TSS":"Total System Services","PEB.AU":"PACIFIC EDGE LTD"},"translate_title":"Pacific Edge表示2026财年第三季度实验室总吞吐量环比下降13%以上","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PEB.AU":1,"PEB.NZ":1.5,"TSS":1.5},"content_text":"Pacific Edge (ASX:PEB, NZE:PEB) said total laboratory throughput in during the the three months to the end of December 2025 fell 13.4% to 5,446 tests from 6,286 in the previous quarter and the total laboratory throughput in US declined 19.5% to 4,003 tests from 4,971 in the second quarter of fiscal 2026, according to separate filings with the Australian and New Zealand bourses on Tuesday.The number of ordering clinicians fell to 691 from 803 in the prior quarter. Asia-Pacific total laboratory throughput rose 9.7% quarter-over-quarter to 1,443 tests from 1,315.Its Chief Executive, Peter Meintjes, said the throughput challenges were amplified by the seasonal holiday slowdown.The firm is also pursuing appeals for all eligible Cxbladder Triage tests that were denied Medicare reimbursement since the Cxbladder non-coverage determination took effect in April 2025. The Office of Medicare Hearings and Appeals (OMHA) notified the firm that the first reimbursement appeal has been scheduled for a hearing before an Administrative Law Judge on Feb. 24.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}